Regulation of P2X7 receptor expression and function in the brain
- PMID: 30593878
- DOI: 10.1016/j.brainresbull.2018.12.008
Regulation of P2X7 receptor expression and function in the brain
Abstract
Because of its prominent role in driving inflammatory processes, the ATP-gated purinergic P2X7 receptor has attracted much attention over the past decade as a potential therapeutic target for numerous human conditions, particularly diseases of the central nervous system, including neurodegenerative diseases (e.g. Alzheimer's and Huntington's disease), psychiatric disorders (e.g. schizophrenia and depression) and the neurological disease, epilepsy. Evidence stems from studies using experimental models and patient tissue showing changes in P2X7 expression and function under pathological conditions and beneficial effects provided by P2X7 antagonism. Apart from promoting neuroinflammation, P2X7, however, also impacts on other pathological processes in the brain, including cell death, hyperexcitability, changes in neurotransmitter release and neurogenesis. Reports also suggest a role for P2X7 in the maintenance of blood-brain-barrier integrity. It therefore comes as no surprise that the regulation of P2X7 expression and function is complex, providing tight control on P2X7 activation. Much progress has been made in understanding how P2X7 is regulated during physiological and pathological conditions and what the consequences are of pathological P2X7 expression and function. Regulatory mechanisms altering P2X7 expression include transcriptional and post-translational regulation including nucleotide polymorphisms, promoter regulation via DNA methylation, transcription factors (e.g. Sp1 and HIF-1α), the generation of different splice variants and receptor phosphorylation, glycosylation and palmitoylation. Finally, more recently, reports have also shown P2X7-targeting by microRNAs, blocking P2X7 translation into functional proteins. The present review provides a broad overview of what is known to-date about the complex regulation of P2X7 expression with a particular emphasis on the brain and how each of these regulatory mechanisms impacts on receptor function and pathology.
Keywords: ATP; Brain; Expression; Purinergic P2X7 receptor.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
A calcium-sensitive feed-forward loop regulating the expression of the ATP-gated purinergic P2X7 receptor via specificity protein 1 and microRNA-22.Biochim Biophys Acta Mol Cell Res. 2017 Feb;1864(2):255-266. doi: 10.1016/j.bbamcr.2016.11.007. Epub 2016 Nov 11. Biochim Biophys Acta Mol Cell Res. 2017. PMID: 27840225
-
The P2X7 Receptor.Adv Exp Med Biol. 2017;1051:17-53. doi: 10.1007/5584_2017_59. Adv Exp Med Biol. 2017. PMID: 28676924 Review.
-
Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.J Neurosci. 2016 Jun 1;36(22):5920-32. doi: 10.1523/JNEUROSCI.4009-15.2016. J Neurosci. 2016. PMID: 27251615 Free PMC article.
-
The specificity protein factor Sp1 mediates transcriptional regulation of P2X7 receptors in the nervous system.J Biol Chem. 2012 Dec 28;287(53):44628-44. doi: 10.1074/jbc.M112.390971. Epub 2012 Nov 8. J Biol Chem. 2012. PMID: 23139414 Free PMC article.
-
The P2X7 Receptor, a Multifaceted Receptor in Alzheimer's Disease.Int J Mol Sci. 2023 Jul 21;24(14):11747. doi: 10.3390/ijms241411747. Int J Mol Sci. 2023. PMID: 37511507 Free PMC article. Review.
Cited by
-
The microRNA-211-5p/P2RX7/ERK/GPX4 axis regulates epilepsy-associated neuronal ferroptosis and oxidative stress.J Neuroinflammation. 2024 Jan 8;21(1):13. doi: 10.1186/s12974-023-03009-z. J Neuroinflammation. 2024. PMID: 38191407 Free PMC article.
-
The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy.Int J Mol Sci. 2023 Mar 12;24(6):5410. doi: 10.3390/ijms24065410. Int J Mol Sci. 2023. PMID: 36982485 Free PMC article. Review.
-
P2X7 receptor-activated microglia in cortex is critical for sleep disorder under neuropathic pain.Front Neurosci. 2023 Feb 3;17:1095718. doi: 10.3389/fnins.2023.1095718. eCollection 2023. Front Neurosci. 2023. PMID: 36816134 Free PMC article.
-
Anti-Inflammatory Activity of 1,4-Naphthoquinones Blocking P2X7 Purinergic Receptors in RAW 264.7 Macrophage Cells.Toxins (Basel). 2023 Jan 5;15(1):47. doi: 10.3390/toxins15010047. Toxins (Basel). 2023. PMID: 36668867 Free PMC article.
-
Increased uptake of the P2X7 receptor radiotracer 18 F-JNJ-64413739 in the brain and peripheral organs according to the severity of status epilepticus in male mice.Epilepsia. 2023 Feb;64(2):511-523. doi: 10.1111/epi.17484. Epub 2022 Dec 27. Epilepsia. 2023. PMID: 36507708 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
